Error: Could not add to watchlist. X

DKB Fonds - Pharma Fonds

+ Watchlist
DKBPHAR:LX
65.56
EUR
1.08
1.67%
As of 11:22:28 ET on 07/02/2015.
Volume
0
Previous Close
64.48
52Wk Range
46.40 - 69.44
1 Yr Return
39.92%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/02/2015)
65.56
Total Assets (m EUR) (on 07/02/2015)
43.248
Inception Date
11/22/1999
Last Dividend (on 05/20/2015)
0.6683
Dividend Indicated Gross Yield
1.02%
Fund Managers
MARKUS HAMELLA
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.40%
Expense Ratio
1.82%
Top Fund Holdings
Name Position Value % of Fund
Pfizer Inc 85.50 k 2.71 m 6.08
Novartis AG 24.53 k 2.34 m 5.25
Merck & Co Inc 36.00 k 1.98 m 4.44
Roche Holding AG 7.00 k 1.91 m 4.30
Gilead Sciences Inc 15.70 k 1.63 m 3.66
Sanofi 15.20 k 1.40 m 3.15
AbbVie Inc 22.50 k 1.40 m 3.13
Allergan plc 4.63 k 1.33 m 2.99
GlaxoSmithKline PLC 61.40 k 1.26 m 2.83
Amgen Inc 8.30 k 1.20 m 2.70
Profile
DKB Pharma Fonds is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term growth. The Fund invests in equities issued by pharmaceutical, technology and biotechnology companies in North America and Europe.
ADDRESS
BayernInvest Luxembourg S.A.
Management S.A.
3, rue Jean Monnet
L-2180 Luxembourg
Luxembourg
PHONE
352-424345464